Advertisement

Human Immunodeficiency Virus Infection and Cytomegalovirus Retinitis

  • Ian Y. WongEmail author
  • Yong Tao
Chapter
Part of the Retina Atlas book series (RA)

Abstract

Cytomegalovirus (CMV) retinitis is the most important blinding complication in patients with human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS). Before the introduction of the highly active or combination antiretroviral therapy (HAART), the incidence of CMV retinitis was as high as 45.3 per 1000 person-years (Schwarcz et al. 2013).

References

  1. Arevalo JF, Mendoza AJ, Ferretti Y. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela. Retina (Philadelphia, Pa). 2003;23(4):495–502.CrossRefGoogle Scholar
  2. Au Eong KG, Beatty S, Charles SJ. Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Postgrad Med J. 1999;75(888):585–90.CrossRefGoogle Scholar
  3. Boss JD, Rosenberg K, Shah R. Dual intravitreal injections with foscarnet and ganciclovir for ganciclovir-resistant recurrent cytomegalovirus retinitis in a congenitally infected infant. J Pediatr Ophthalmol Strabismus. 2016;53:e58–60.  https://doi.org/10.3928/01913913-20161003-02.CrossRefPubMedGoogle Scholar
  4. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–13.  https://doi.org/10.1002/rmv.655.CrossRefPubMedGoogle Scholar
  5. Cheung CY, Wong IY, Yan KW, Kwong YL. Cytomegalovirus oral lesions: harbinger of retinitis in the absence of viraemia. Ann Hematol. 2014;93(9):1613–5.  https://doi.org/10.1007/s00277-014-2008-1.CrossRefPubMedGoogle Scholar
  6. Freeman WR. Retinal detachment in cytomegalovirus retinitis: should our approach be changed? Retina (Philadelphia, Pa). 1999;19(4):271–3.CrossRefGoogle Scholar
  7. Freeman WR, Friedberg DN, Berry C, Quiceno JI, Behette M, Fullerton SC, Munguia D. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993;116(6):713–20.CrossRefGoogle Scholar
  8. Freeman WR, Quiceno JI, Crapotta JA, Listhaus A, Munguia D, Aguilar MF. Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis. Ophthalmology. 1992;99(3):466–74.CrossRefGoogle Scholar
  9. Gross JG, Bozzette SA, Mathews WC, Spector SA, Abramson IS, McCutchan JA, Mendez T, Munguia D, Freeman WR. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1990;97(5):681–6.CrossRefGoogle Scholar
  10. Hassan J, O’Neill D, Honari B, De Gascun C, Connell J, Keogan M, Hickey D. Cytomegalovirus Infection in Ireland: seroprevalence, HLA class I alleles, and implications. Medicine. 2016;95(6):e2735.  https://doi.org/10.1097/md.0000000000002735.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Henry K, Cantrill H, Fletcher C, Chinnock BJ, Balfour HH Jr. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol. 1987;103(1):17–23.CrossRefGoogle Scholar
  12. Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group. Arch Ophthalmol. 1989;107(12):1759–66.CrossRefGoogle Scholar
  13. Iu LP, Fan MC, Lau JK, Chan TS, Kwong YL, Wong IY. Long-term follow-up of cytomegalovirus retinitis in non-HIV immunocompromised patients: clinical features and visual prognosis. Am J Ophthalmol. 2016;165:145–53.  https://doi.org/10.1016/j.ajo.2016.03.015.CrossRefPubMedGoogle Scholar
  14. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107(1):75–80.CrossRefGoogle Scholar
  15. Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2002;133(1):48–61.CrossRefGoogle Scholar
  16. Jeon S, Lee WK, Lee Y, Lee DG, Lee JW. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation. Ophthalmology. 2012;119(9):1892–8.  https://doi.org/10.1016/j.ophtha.2012.03.032.CrossRefPubMedGoogle Scholar
  17. Kangro HO, Osman HK, Lau YL, Heath RB, Yeung CY, Ng MH. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol. 1994;43(1):91–6.CrossRefGoogle Scholar
  18. Karavellas MP, Song M, Macdonald JC, Freeman WR. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol. 2000;130(1):57–64.CrossRefGoogle Scholar
  19. Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol. 2001;119(1):33–40.PubMedGoogle Scholar
  20. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol. 2003;121(4):466–76.  https://doi.org/10.1001/archopht.121.4.466.CrossRefPubMedGoogle Scholar
  21. Korndewal MJ, Mollema L, Tcherniaeva I, van der Klis F, Kroes AC, Oudesluys-Murphy AM, Vossen AC, de Melker HE. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol. 2015;63:53–8.  https://doi.org/10.1016/j.jcv.2014.11.033.CrossRefPubMedGoogle Scholar
  22. Kuppermann BD, Petty JG, Richman DD, Mathews WC, Fullerton SC, Rickman LS, Freeman WR. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115(5):575–82.CrossRefGoogle Scholar
  23. Lieberman RM, Orellana J, Melton RC. Efficacy of intravitreal foscarnet in a patient with AIDS. N Engl J Med. 1994;330(12):868–9.  https://doi.org/10.1056/nejm199403243301219.CrossRefPubMedGoogle Scholar
  24. Martin DF, Parks DJ, Mellow SD, Ferris FL, Walton RC, Remaley NA, Chew EY, Ashton P, Davis MD, Nussenblatt RB. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol. 1994;112(12):1531–9.CrossRefGoogle Scholar
  25. Miao H, Tao Y, Jiang YR, Li XX. Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle. Fortschr Ophthalmol. 2013;251(7):1829–33.  https://doi.org/10.1007/s00417-013-2368-6.CrossRefGoogle Scholar
  26. Newsom R, Casswell T, O’Moore E, Fisher M. Cystoid macular oedema in patients with AIDS and cytomegalovirus retinitis on highly active antiretroviral therapy. Br J Ophthalmol. 1998;82(4):456–7.CrossRefGoogle Scholar
  27. Schwarcz L, Chen MJ, Vittinghoff E, Hsu L, Schwarcz S. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance. AIDS (London, England). 2013;27(4):597–605.  https://doi.org/10.1097/QAD.0b013e32835b0fa2.CrossRefGoogle Scholar
  28. Shigemi D, Yamaguchi S, Otsuka T, Kamoi S, Takeshita T. Seroprevalence of cytomegalovirus IgG antibodies among pregnant women in Japan from 2009-2014. Am J Infect Control. 2015;43(11):1218–21.  https://doi.org/10.1016/j.ajic.2015.06.026.CrossRefPubMedGoogle Scholar
  29. Stewart MW. Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol. 2010;4:285–99.CrossRefGoogle Scholar
  30. Tabatabaee M, Tayyebi D. Seroepidemiologic study of human cytomegalovirus in pregnant women in Valiasr Hospital of Kazeroon, Fars, Iran. J Matern Fetal Neonatal Med. 2009;22(6):517–21.  https://doi.org/10.1080/14767050902801678.CrossRefPubMedGoogle Scholar
  31. Teoh SC, Wang PX, Wong EP. The epidemiology and incidence of cytomegalovirus retinitis in the HIV population in Singapore over 6 years. Invest Ophthalmol Vis Sci. 2012;53(12):7546–52.  https://doi.org/10.1167/iovs.12-10349.CrossRefPubMedGoogle Scholar
  32. Wang B, Tian B, Tao Y, Hou J, Zhao XT, Li XX. Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis. J Ocul Pharmacol Ther. 2014;30(7):587–92.  https://doi.org/10.1089/jop.2013.0241.CrossRefPubMedPubMedCentralGoogle Scholar
  33. Whitcup SM. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA. 2000;283(5):653–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Li Ka Shing Faculty of Medicine, The University of Hong KongHong KongChina
  2. 2.Department of OphthalmologyBeijing Chaoyang Hospital, Capital Medical UniversityBeijingChina

Personalised recommendations